Insider Transactions in Q1 2021 at Aprea Therapeutics, Inc. (APRE)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 10
2021
|
Gregory Alan Korbel SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+37.04%
|
-
|
|
Feb 25
2021
|
Gregory Alan Korbel SVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+48.78%
|
-
|
|
Feb 25
2021
|
Scott M Coiante SVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
96,500
+43.63%
|
-
|
|
Feb 25
2021
|
Christian S Schade Director |
BUY
Grant, award, or other acquisition
|
Direct |
165,500
+41.66%
|
-
|
|
Feb 25
2021
|
Lars B. Abrahmsen SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+50.0%
|
-
|
|
Feb 25
2021
|
Gregory S. Wessels SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,000
+50.0%
|
-
|
|
Feb 25
2021
|
Eyal C. Attar SVP, Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
108,000
+45.49%
|
-
|